-transparent.png){kind=logo}
Multiple drug resistance to antibacterial agents, antifungals, antivirals, antiprotozoals, and antitumor agents has risen spectacularly in the last decade or so and presently threatens eventually to put an end to successful chemotherapy in all of the above fields. This review summarizes the known origins of the problem, its present dimensions, the means employed to combat the phenomenon and promising avenues for future developments.
Related Publications
L A Mitscher, and
S P Pillai, and
E J Gentry, and
D M Shankel
January 1994,
Lijecnicki vjesnik,
L A Mitscher, and
S P Pillai, and
E J Gentry, and
D M Shankel
January 1993,
Advances in veterinary science and comparative medicine,
L A Mitscher, and
S P Pillai, and
E J Gentry, and
D M Shankel
January 1968,
New Zealand veterinary journal,
L A Mitscher, and
S P Pillai, and
E J Gentry, and
D M Shankel
January 1995,
The Iowa orthopaedic journal,
L A Mitscher, and
S P Pillai, and
E J Gentry, and
D M Shankel
October 1997,
Seminars in hematology,
L A Mitscher, and
S P Pillai, and
E J Gentry, and
D M Shankel
February 1999,
Pathologie-biologie,
L A Mitscher, and
S P Pillai, and
E J Gentry, and
D M Shankel
April 1993,
International journal of oncology,
L A Mitscher, and
S P Pillai, and
E J Gentry, and
D M Shankel
April 1968,
Missouri medicine,
L A Mitscher, and
S P Pillai, and
E J Gentry, and
D M Shankel
September 1997,
Chest,
L A Mitscher, and
S P Pillai, and
E J Gentry, and
D M Shankel
March 1984,
Indian journal of medical sciences,
